Dermata Therapeutics, Inc. (DRMA)
0.8699
+0.01
(+1.16%)
USD |
NASDAQ |
Oct 20, 16:00
0.85
-0.02
(-2.29%)
After-Hours: 06:22
Dermata Therapeutics EPS Diluted (Quarterly) : -0.7377 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.7377 |
| March 31, 2026 | -0.4788 |
| December 31, 2025 | -1.522 |
| September 30, 2025 | -1.648 |
| June 30, 2025 | -1.657 |
| March 31, 2025 | -0.4469 |
| December 31, 2024 | -12.51 |
| September 30, 2024 | -2.041 |
| June 30, 2024 | -4.182 |
| March 31, 2024 | -7.058 |
| December 31, 2023 | -8.143 |
| September 30, 2023 | -8.086 |
| June 30, 2023 | -9.435 |
| Date | Value |
|---|---|
| March 31, 2023 | -34.08 |
| December 31, 2022 | -32.52 |
| September 30, 2022 | -47.40 |
| June 30, 2022 | -58.54 |
| March 31, 2022 | -80.06 |
| December 31, 2021 | -73.56 |
| September 30, 2021 | -123.19 |
| June 30, 2021 | -38.38 |
| March 31, 2021 | -66.42 |
| September 30, 2020 | -17.22 |
| June 30, 2020 | -23.68 |
| March 31, 2020 | -40.95 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 0.2412 |
| Perspective Therapeutics, Inc. | -0.222 |
| MiMedx Group, Inc. | -0.1004 |
| ABVC BioPharma, Inc. | -0.0283 |
| Agilent Technologies, Inc. | 1.279 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.967M |
| Total Expenses (Quarterly) | 2.967M |
| Enterprise Value | -0.914M |
| Earnings Yield | -504.2% |
| Normalized Earnings Yield | -504.24 |